Year |
Citation |
Score |
2019 |
Srivastava P, Tzetzo S, Cortes Gomez E, Eng K, Singh PK, De Jong K, Sait SNJ, Wiatrowski K, Lynch ML, Peresie J, Wang J, Griffiths EA, Nemeth MJ. Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141Hi Conventional Dendritic Cells Blood. 134: 1695-1695. DOI: 10.1182/Blood-2019-126220 |
0.348 |
|
2004 |
Nemeth MJ, Lowrey CH. An Erythroid-Specific Chromatin Opening Element Increases β-Globin Gene Expression from Integrated Retroviral Gene Transfer Vectors. Gene Therapy & Molecular Biology. 8: 475-486. PMID 16670777 |
0.719 |
|
2004 |
Pal S, Nemeth MJ, Bodine D, Miller JL, Svaren J, Thein SL, Lowry PJ, Bresnick EH. Neurokinin-B transcription in erythroid cells: direct activation by the hematopoietic transcription factor GATA-1. The Journal of Biological Chemistry. 279: 31348-56. PMID 15123623 DOI: 10.1074/Jbc.M403475200 |
0.354 |
|
2002 |
Kitareewan S, Pitha-Rowe I, Sekula D, Lowrey CH, Nemeth MJ, Golub TR, Freemantle SJ, Dmitrovsky E. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 99: 3806-11. PMID 11891284 DOI: 10.1073/Pnas.052011299 |
0.632 |
|
2001 |
Nemeth MJ, Bodine DM, Garrett LJ, Lowrey CH. An erythroid-specific chromatin opening element reorganizes beta-globin promoter chromatin structure and augments gene expression. Blood Cells, Molecules & Diseases. 27: 767-80. PMID 11778661 DOI: 10.1006/Bcmd.2001.0448 |
0.756 |
|
2000 |
McInerney JM, Nemeth MJ, Lowrey CH. Erythropoiesis: Review Article: Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of beta-Thalassemia and Sickle Cell Disease. Hematology (Amsterdam, Netherlands). 4: 437-455. PMID 11399586 |
0.717 |
|
1999 |
Mcinerney JM, Nemeth MJ, Lowrey CH. Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease. Hematology (Amsterdam, Netherlands). 4: 437-55. PMID 27426849 DOI: 10.1080/10245332.1999.11746470 |
0.673 |
|
1999 |
Iler N, Goodwin AJ, McInerney J, Nemeth MJ, Pomerantz O, Layon ME, Lowrey CH. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing. Blood Cells, Molecules & Diseases. 25: 47-60. PMID 10349513 DOI: 10.1006/Bcmd.1999.0226 |
0.567 |
|
1998 |
Hamilton JW, Kaltreider RC, Bajenova OV, Ihnat MA, McCaffrey J, Turpie BW, Rowell EE, Oh J, Nemeth MJ, Pesce CA, Lariviere JP. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environmental Health Perspectives. 106: 1005-15. PMID 9703486 DOI: 10.1289/Ehp.98106S41005 |
0.463 |
|
Show low-probability matches. |